Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma

Daniela Buglio, Noor M. Khaskhely, Kui Shin Voo, Hector Martinez-Valdez, Yong-Jun Liu, Anas Younes

Blood (2011) 117 (10): 2910–2917.

https://doi.org/10.1182/blood-2010-08-303701

Published: 2011

Journal Articles

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

Noor M Khaskhely, MD, PhD, Daniela Buglio, MD, Jessica Shafer, MD, Catherine M. Bollard, MD, FRACP, FRCPA, Anas Younes, MD

Blood (2009) 114 (22): 1562.

https://doi.org/10.1182/blood.V114.22.1562.1562

Published: 2009

Journal Articles

The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.

Daniela Buglio, MD, Vidya Mamidipudi, Noor M Khaskhely, MD, PhD, Annunziata Gloghini, Antonino Carbone, MD, Carla Heise, Jeffrey M. Besterman, PhD, BSc, Robert E Martell, Kyle J MacBeth, Anas Younes, MD

Blood (2009) 114 (22): 3735.

https://doi.org/10.1182/blood.V114.22.3735.3735

Published: 2009

Journal Articles

Differential Effect of the Histone Deacetylase Inhibitors Vorinostat and MGCD0103 in Cell-Free and Cell-Based Assays

Daniela Buglio, MD, Noor M Khaskhely, MD, PhD, George V Georgakis, MD, Anas Younes, MD

Blood (2008) 112 (11): 4827.

https://doi.org/10.1182/blood.V112.11.4827.4827

Published: 2008

Journal Articles

Vorinostat inhibits STAT6-mediated T H 2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

Daniela Buglio, Georgios V. Georgakis, Shino Hanabuchi, Kazuhiko Arima, Noor M. Khaskhely, Yong-Jun Liu, Anas Younes

Blood (2008) 112 (4): 1424–1433.

https://doi.org/10.1182/blood-2008-01-133769

Published: 2008

Includes: Supplemental data

NARROW

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.

Differential Effect of the Histone Deacetylase Inhibitors Vorinostat and MGCD0103 in Cell-Free and Cell-Based Assays

Vorinostat inhibits STAT6-mediated T H 2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

Email alerts

ASH Publications

American Society of Hematology

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.

Differential Effect of the Histone Deacetylase Inhibitors Vorinostat and MGCD0103 in Cell-Free and Cell-Based Assays

Vorinostat inhibits STAT6-mediated T H 2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only